Related Experiment Video
Updated: Nov 28, 2025

Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans
Published on: December 9, 2022
FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease
Randi Chen1, Brian J Morris1,2,3, Timothy A Donlon1,4,5
1Department of Research, Kuakini Medical Center, Honolulu, HI 96817, USA.
Insights
The longevity gene FOXO3 extends lifespan in individuals with cardiometabolic diseases (CMD). This FOXO3 longevity genotype offers protection against cardiometabolic stress, improving survival in at-risk populations.
Area of Science:
- Genetics
- Longevity research
- Cardiovascular health
Background:
- The gene FOXO3 is recognized as a significant longevity gene.
- Previous research has not clarified if FOXO3 variants protect against mortality in all individuals or only those with age-related diseases.
Purpose of the Study:
- To investigate whether longevity-associated FOXO3 genetic variants are associated with mortality protection in individuals with and without cardiometabolic disease (CMD).
Main Methods:
- Examined longevity-associated FOXO3 single nucleotide polymorphisms in a haplotype block.
- Analyzed mortality data in 3,584 elderly American men of Japanese ancestry (2,512 with CMD, 1,072 without).
- Assessed baseline CMD conditions including diabetes, hypertension, and coronary heart disease (CHD).
Main Results:
- In individuals with CMD, longevity-associated FOXO3 alleles were linked to significantly longer lifespan (hazard ratio 0.81).
- Men with CMD and the FOXO3 longevity genotype exhibited survival rates similar to men without CMD.
- No association between FOXO3 longevity alleles and lifespan was observed in men without CMD.
Conclusions:
- The FOXO3 longevity genotype appears to increase lifespan specifically in individuals at risk due to cardiometabolic stress.
- This study provides new insights into the role of FOXO3 in longevity, particularly its protective effects against mortality in the context of aging-related diseases.
Abstract:
FOXO3 is a prominent longevity gene. To date, no-one has examined whether longevity-associated FOXO3 genetic variants protect against mortality in all individuals, or only in those with aging-related diseases. We therefore tested longevity-associated FOXO3 single nucleotide polymorphisms in a haplotype block for association with mortality in 3,584 elderly American men of Japanese ancestry, 2,512 with and 1,072 without a cardiometabolic disease (CMD). At baseline (1991-1993), 1,010 CMD subjects had diabetes, 1,919 had hypertension, and 738 had coronary heart disease (CHD). Follow-up until Dec 31, 2019 found that in CMD-affected individuals, longevity-associated alleles of FOXO3 were associated with significantly longer lifespan: haplotype hazard ratio 0.81 (95% CI 0.72-0.91; diabetes 0.77, hypertension 0.82, CHD 0.83). Overall, men with a CMD had higher mortality than men without a CMD (P=6x10-7). However, those men with a CMD who had the FOXO3 longevity genotype had similar survival as men without a CMD. In men without a CMD there was no association of longevity-associated alleles of FOXO3 with lifespan. Our study provides novel insights into the basis for the long-established role of FOXO3 as a longevity gene. We suggest that the FOXO3 longevity genotype increases lifespan only in at-risk individuals by protection against cardiometabolic stress.
More Related Videos
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Animal Mitochondrial Genetics
X-linked Traits
Regulation of Metabolism
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy II: Dilated Cardiomyopathy